Response of the author to the letter “Cost-effectiveness study of leflunomide versus methotrexate”
Respuesta del autor a la carta «Estudio coste-efectividad de leflunomida frente a metrotexato»
Read
3939
Timeswas read the article
1994
Total PDF
1945
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 10 | 11 |
| 2025 5 | 62 | 32 | 94 |
| 2025 4 | 36 | 22 | 58 |
| 2025 3 | 52 | 30 | 82 |
| 2025 2 | 34 | 27 | 61 |
| 2025 1 | 36 | 51 | 87 |
| 2024 12 | 22 | 26 | 48 |
| 2024 11 | 37 | 63 | 100 |
| 2024 10 | 22 | 31 | 53 |
| 2024 9 | 20 | 20 | 40 |
| 2024 8 | 38 | 33 | 71 |
| 2024 7 | 24 | 32 | 56 |
| 2024 6 | 25 | 23 | 48 |
| 2024 5 | 16 | 15 | 31 |
| 2024 4 | 14 | 16 | 30 |
| 2024 3 | 20 | 22 | 42 |
| 2024 2 | 17 | 18 | 35 |
| 2024 1 | 13 | 20 | 33 |
| 2023 12 | 14 | 21 | 35 |
| 2023 11 | 15 | 21 | 36 |
| 2023 10 | 27 | 21 | 48 |
| 2023 9 | 16 | 31 | 47 |
| 2023 8 | 14 | 16 | 30 |
| 2023 7 | 25 | 15 | 40 |
| 2023 6 | 17 | 23 | 40 |
| 2023 5 | 17 | 12 | 29 |
| 2023 4 | 17 | 11 | 28 |
| 2023 3 | 23 | 29 | 52 |
| 2023 2 | 15 | 34 | 49 |
| 2023 1 | 19 | 27 | 46 |
| 2022 12 | 19 | 34 | 53 |
| 2022 11 | 23 | 30 | 53 |
| 2022 10 | 23 | 45 | 68 |
| 2022 9 | 20 | 30 | 50 |
| 2022 8 | 24 | 38 | 62 |
| 2022 7 | 44 | 37 | 81 |
| 2022 6 | 38 | 35 | 73 |
| 2022 5 | 24 | 40 | 64 |
| 2022 4 | 15 | 41 | 56 |
| 2022 3 | 19 | 33 | 52 |
| 2022 2 | 19 | 24 | 43 |
| 2022 1 | 9 | 38 | 47 |
| 2021 12 | 21 | 34 | 55 |
| 2021 11 | 24 | 48 | 72 |
| 2021 10 | 24 | 53 | 77 |
| 2021 9 | 31 | 45 | 76 |
| 2021 8 | 18 | 37 | 55 |
| 2021 7 | 14 | 31 | 45 |
| 2021 6 | 34 | 40 | 74 |
| 2021 5 | 15 | 31 | 46 |
| 2021 4 | 50 | 103 | 153 |
| 2021 3 | 36 | 43 | 79 |
| 2021 2 | 26 | 19 | 45 |
| 2021 1 | 17 | 13 | 30 |
| 2020 12 | 12 | 21 | 33 |
| 2020 11 | 11 | 14 | 25 |
| 2020 10 | 7 | 9 | 16 |
| 2020 9 | 74 | 20 | 94 |
| 2020 8 | 73 | 15 | 88 |
| 2020 7 | 29 | 11 | 40 |
| 2020 6 | 28 | 21 | 49 |
| 2020 5 | 37 | 18 | 55 |
| 2020 4 | 44 | 17 | 61 |
| 2020 3 | 14 | 10 | 24 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 3 | 1 | 4 |
| 2018 4 | 15 | 7 | 22 |
| 2018 3 | 21 | 10 | 31 |
| 2018 2 | 19 | 2 | 21 |
| 2018 1 | 2 | 2 | 4 |
| 2017 12 | 8 | 5 | 13 |
| 2017 11 | 6 | 7 | 13 |
| 2017 10 | 10 | 6 | 16 |
| 2017 9 | 13 | 4 | 17 |
| 2017 8 | 5 | 11 | 16 |
| 2017 7 | 9 | 10 | 19 |
| 2017 6 | 15 | 6 | 21 |
| 2017 5 | 17 | 9 | 26 |
| 2017 4 | 7 | 6 | 13 |
| 2017 3 | 12 | 16 | 28 |
| 2017 2 | 4 | 9 | 13 |
| 2017 1 | 12 | 2 | 14 |
| 2016 12 | 29 | 12 | 41 |
| 2016 11 | 17 | 2 | 19 |
| 2016 10 | 32 | 12 | 44 |
| 2016 9 | 22 | 7 | 29 |
| 2016 8 | 17 | 7 | 24 |
| 2016 7 | 13 | 11 | 24 |
Show all
